Abstract:LPS has been shown to elicit neuroinflammation associated with the up-regulation of the eicosanoid pathway in animal models; however, the regulatory mechanisms of TLR4 in brain neuroinflammatory conditions remain elusive. -Arrestins are key regulators of the GPCR signaling pathway and are involved in the leukotriene B4-induced leukocyte migration to initiate inflammatory response. However, the roles of -arrestins in eicosanoid regulation and related diseases are not clear. To address this issue, we conducted a study to investigate the effect of TLR4 on the eicosanoid pathway in ischemic stroke brain and to explore the underlying molecular regulation mechanism. Cerebral ischemia was produced by occlusion of the middle cerebral artery, followed by reperfusion for 24 h. We demonstrated that knockout of TLR4 improves ischemic stroke brain associated with eicosanoid down-regulation. Interestingly, genetic disruption of -arrestin-2 failed to decrease neuroinflammation in the damaged brain of TLR4(-/-) mice, which indicates the requirement of -arrestin-2 for TLR4 knockdown protection. Further study showed that the negative regulation of phosphorylated (phospho-)ERK1/2 and phospho-cytosolic phospholipase A(2) (cPLA(2)) by TLR4 deficiency was eliminated by genetic disruption of -arrestin-2. In addition, -arrestin-2 deficiency reversed the reduction of colocalization of phospho-ERK1/2 with phospho-cPLA(2) in TLR4(-/-) mice following ischemic stroke. Mechanistic studies indicated that -arrestin-2 specifically colocalized and associated with ERK1/2 to prevent ERK1/2-dependent cPLA(2) activation following ischemic injury, and -arrestin-2 deficiency blocked the negative regulation of phospho-ERK1/2, revived the association of phospho-ERK1/2 with phospho-cPLA(2), and subsequently increased the prostaglandin E2 and thromboxane A2 production remarkably. Our findings may provide novel insights that -arrestin-2 is responsible for ischemic brain improvement in TLR4(-/-) mice via negative regulation of eicosanoid production.Xiang, Y., Wei, X., Du, P., Zhao, H., Liu, A., Chen, Y. -Arrestin-2-ERK1/2 cPLA(2) axis mediates TLR4 signaling to influence eicosanoid induction in ischemic brain.

β-Arrestin-2-ERK1/2 cPLA 2 α axis mediates TLR4 signaling to influence eicosanoid induction in ischemic brain.

Β-Arrestin 2 Negatively Regulates Toll-like Receptor 4 (Tlr4)-Triggered Inflammatory Signaling Via Targeting P38 MAPK and Interleukin 10.

β-arrestin 2 attenuates lipopolysaccharide-induced liver injury via inhibition of TLR4/NF-κB signaling pathway-mediated inflammation in mice.

β-arrestin 2 negatively regulates NOD2 signalling pathway through association with TRAF6 in microglia after cerebral ischaemia/reperfusion injury.

TRPM2 channel regulates cytokines production in astrocytes and aggravates brain disorder during lipopolysaccharide-induced endotoxin sepsis.

Inhibition of LAR attenuates neuroinflammation through RhoA/IRS-1/Akt signaling pathway after intracerebral hemorrhage in mice

TLR4 Enhances Cerebral Ischemia/Reperfusion Injury via Regulating NLRP3 Inflammasome and Autophagy

TLR4 signaling pathway mediates the LPS/ischemia-induced expression of monocytechemotactic protein-induced protein 1 in microglia

Inhibition of Spla2-Iia Prevents LPS-Induced Neuroinflammation by Suppressing ERK1/2-cPLA2α Pathway in Mice Cerebral Cortex

Inhibition of Mek/Erk 1/2 Pathway Reduces Pro-Inflammatory Cytokine Interleukin-1 Expression in Focal Cerebral Ischemia

S1PR2 antagonist alleviates oxidative stress-enhanced brain endothelial permeability by attenuating p38 and Erk1/2-dependent cPLA2 phosphorylation

Cerebral Ischemia-Reperfusion Injury: Lysophosphatidic Acid Mediates Inflammation by Decreasing the Expression of Liver X Receptor

The role and mechanism of β-arrestin2 in signal transduction

Activation of bradykinin B2 receptor induced the inflammatory responses of cytosolic phospholipase A after the early traumatic brain injury.

Thromboxane A2 Receptor Stimulation Enhances Microglial Interleukin-1β and NO Biosynthesis Mediated by the Activation of ERK Pathway

Spata2 Knockdown Exacerbates Brain Inflammation via NF-κB/P38MAPK Signaling and NLRP3 Inflammasome Activation in Cerebral Ischemia/Reperfusion Rats

The LPS-inactivating enzyme acyloxyacyl hydrolase protects the brain from experimental stroke

β-Arrestin 2 regulates toll-like receptor 4-mediated apoptotic signalling through glycogen synthase kinase-3β: β-arrestin 2 regulates TLR4-mediated apoptosis

Protective Effect of Cytosolic Phospholipase A2 Inhibition Against Inflammation and Degeneration by Promoting Regulatory T Cells in Rats with Experimental Autoimmune Encephalomyelitis

Ligustilide Ameliorates Neuroinflammation and Brain Injury in Focal Cerebral Ischemia/reperfusion Rats: Involvement of Inhibition of TLR4/peroxiredoxin 6 Signaling.

Increased expression of beta-arrestin 1 and 2 in murine models of rheumatoid arthritis: isoform specific regulation of inflammation.